Skip to main content

Table 3 Differences in ADC value, MK value and MD between the PR group and the non-PR group before and after first-line chemotherapy in patients with unresectable pancreatic cancer

From: Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer

Parameters

PR*

non-PR*

P value

ADC(×10− 3mm2/s)

   

ADCpre

1.00 ± 0.55

1.02 ± 0.14

0.734

ADCpost

1.21 ± 0.09

1.13 ± 0.16

0.09

ADCchange

0.21 ± 0.05

0.11 ± 0.09

0.02

MK

   

MKpre

0.67 ± 0.05

0.70 ± 0.11

0.686

Mkpost

0.58 ± 0.05

0.61 ± 0.09

0.289

Mkchange

-0.15 ± 0.11

-0.12 ± 0.09

0.573

MD(×10− 3mm2/s)

   

MDpre

1.72 ± 0.21

1.89 ± 0.30

0.153

MDpost

2.35 ± 0.41

2.08 ± 0.40

0.166

MDchange

0.37 ± 0.24

0.10 ± 0.12

0.002

  1. Note: *All of the data represent the mean ± standard deviation; MKchange=(MKpre−MKpost)/MKpre; MDchange=(MDpost−MDpre)/MDpre; ADCchange=(ADCpost−ADCpre)/ADCpre